PMA device
Nucleus Cochlear Implant Systems
Cochlear Americas · Implant, Cochlear (MCM, Class III) · First FDA decision Aug 24, 2009, newest Oct 31, 2022Hearing loss
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
17
PMA pathway
Device trials
459
Naming "Nucleus"
MAUDE reports
22,508
Brand "Nucleus", since 2015
PubMed studies
290,264
Mentioning "Nucleus"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Nucleus Cochlear Implant Systems
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 17 decisions filed under this name.
- Nucleus Cochlear Implant SystemsPMA supplement
P970051-S211 · Decided Oct 31, 2022 · 188 days after receipt · Normal 180 Day Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
- Nucleus Cochlear Implant SystemPMA supplement
P970051-S197 · Decided Aug 31, 2020 · 180 days after receipt · Normal 180 Day Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
- Nucleus Cochlear Implant SystemPMA supplement
P970051-S185 · Decided Nov 8, 2019 · 177 days after receipt · Normal 180 Day Track
Device type: Implant, cochlear (MCM) · Otolaryngology (ENT)
3 more FDA decisions with a free account
Older decisions: P970051-S140, P970051-S137, P970051-S104, P970051-S094, P970051-S091, P970051-S064, P970051-S053, P970051-S049, P970051-S048, P890027-S062, P840024-S094
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cochlear ImplantationNational analysisReview closedCAG-00107RUpdated Sep 17, 2026
- Cochlear ImplantationNational analysisReview closedCAG-00107NUpdated Sep 17, 2026
- Cochlear ImplantationNational determinationOn the books50.3Updated Mar 26, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Nucleus", any status and sponsor, newest update first.
- A Phase 2 Study of Dynamic BH3 Profiling (DBP) Guided Combination Therapy in Subjects With R/R AMLNot yet recruiting
Dana-Farber Cancer InstituteAcademic, hospital or other
NCT07949370 · 40 participants (planned) · Start Mar 6, 2027 · Primary completion Dec 31, 2029
Device: Dynamic BH3 Profiling · For: Relapsed or Refractory Acute Myeloid Leukemia (AML)
Sites: Boston, Massachusetts · 2 sites in all
- Combating Related Epidemics in HCVPivotal-lookingNot yet recruiting
Duke UniversityAcademic, hospital or other
NCT07560046 · 1,280 participants (planned) · Start Jan 20, 2027 · Primary completion Nov 30, 2029
Device: Cepheid GeneXpert HCV Test · For: HIV - Human Immunodeficiency Virus; Hepatitis B Virus (HBV); HEPATITIS C (HCV)
Ruijin HospitalAcademic, hospital or other
NCT07018388 · 30 participants · Start Aug 25, 2025 · Primary completion Apr 10, 2026
Device: Transcranial temporal interference stimulation; Transcranial temporal interference stimulation and 1 more · For: Parkinson Disease
Sites: Shanghai, China
456 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Nucleus", and for the whole product code for context.
This brand
22,508 reports: 3,403 malfunction, 19,090 injury, 12 death
Whole product code MCM
51,927 reports: 19,701 malfunction, 32,181 injury, 22 death
Newest reports for this brand
6000034-2026-03892 · Received Oct 30, 2026
Device type: Implant, Cochlear (MCM)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Headache; Pain
6000034-2026-03891 · Received Oct 30, 2026
Device type: Implant, Cochlear (MCM)
Device problem as coded: Appropriate Device Problem Term/Code Not Available
Patient problem as coded: Headache; Pain
- Nucleus 22Injury
6000034-2026-03867 · Received Oct 30, 2026
Device type: Implant, Cochlear (MCM)
Device problem as coded: Therapeutic or Diagnostic Output Failure
Patient problem as coded: Undesired Nerve Stimulation
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2155-2015 · Started Jun 5, 2015 · Posted by FDA Jul 20, 2015
Reason given: Cochlear Americas is recalling Nucleus Sterile Silicone Template CI24RE/CI422 part number Z421736 because expired product was distributed.
Cause as FDA categorized it: Process control · Device type: Implant, Cochlear (MCM)
Z-0003-2012 · Started Sep 16, 2011 · Posted by FDA Oct 3, 2011
Reason given: Cochlear implant may shut down and cease to function.
Cause as FDA categorized it: Component design/selection · Device type: Implant, Cochlear (MCM)
- Nucleus Non-Magnetic Plug for removable magnet implants, REF Z50100, STERILE EO, Cochlear Limited.Terminated
Z-0119-2010 · Started Sep 30, 2009 · Posted by FDA Nov 2, 2009
Reason given: Cochlear implant device component was mis-labeled.
Cause as FDA categorized it: Labeling mix-ups · Device type: Implant, Cochlear (MCM)
Published research
The most relevant PubMed records for "Nucleus"[tiab]. The summary above synthesizes these.
- Nucleus-splitting phacoemulsification technique.
Smith SG · J Cataract Refract Surg · 1991
- Asesino: a nucleus-forming phage that lacks PhuZ.
Prichard A, Sy A, Meyer J, et al. · bioRxiv · 2024Preprint
- Nucleus-Targeting Phototherapy Nanodrugs for High-Effective Anti-Cancer Treatment.
Long X, Zhang X, Chen Q, et al. · Front Pharmacol · 2022Review
- Afferents of the mouse linear nucleus.
Liang H, Paxinos G · Mol Brain · 2020Research Support, Non-U.S. Gov't
- Connections of the precommissural nucleus.
Canteras NS, Goto M · J Comp Neurol · 1999Research Support, Non-U.S. Gov't
- Nucleus pulposus allograft retards intervertebral disc degeneration.
Nomura T, Mochida J, Okuma M, et al. · Clin Orthop Relat Res · 2001Research Support, Non-U.S. Gov't
- The Neutrophil Nucleus and Its Role in Neutrophilic Function.
Carvalho LO, Aquino EN, Neves AC, et al. · J Cell Biochem · 2015Review
- Nucleus prepositus hypoglossi. A medullary pressor region.
Talman WT, Robertson SC · Hypertension · 1991Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
- Nucleus-targeting pH-Responsive carbon dots for fast nucleus pH detection.
Durrani S, Yang Z, Zhang J, et al. · Talanta · 2023
- Subthalamic projection to nucleus tegmenti pedunculopontinus in the rat.
Jackson A, Crossman AR · Neurosci Lett · 1981
Other devices of this type
Also filed under product code MCM.
- HiResolution Bionic Ear SystemAdvanced Bionics · PMA 2026
- Nucleus® 24 Cochlear Implant SystemCochlear Americas · PMA 2025
- COMBI 40+ Cochlear Implant SystemMed-El Corp. · PMA 2019
- Nucleus® 22 Cochlear Implant SystemCochlear Americas · PMA 2025
- MED-EL Cochlear ImplantMed-El Corp. · PMA 2026
- Harmony Hiresolution Bionic Ear SystemAdvanced Bionics · PMA 2012
- Clarion Multi-Strategy Cochlear ImplantAdvanced Bionics · PMA 2026
- Nucleus 24 Auditory Brainstem ImplantCochlear Americas · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.